MedCity News November 4, 2022
Angel Rodriguez

As supply chain disruptions continue to threaten public health, it’s time to think about how we should use technology to build a stronger, more resilient system.

Iodinated contrast media, used in many imaging exams, was in short supply for about six months, after a Covid-19 lockdown temporarily shuttered a GE Healthcare factory in China, which was a major supplier of the material. As a consequence, doctors in the U.S. were forced to postpone non-emergency monitoring appointments, putting thousands of patients at risk of missing critical, early warning signs of disease progression. While the shortage was originally expected to last until June, it didn’t officially end until the end of September. Now that it’s finally over, it’s time to examine what...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Healthcare System, Investments, Provider, Public Health / COVID, Supply Chain, Technology, Telehealth, Trends
Musk bashes Trump-backed Stargate deal: "They don't actually have the money"
What is the ‘Stargate’ AI project?
How Stargate Partners Oracle, Open AI, Nvidia And Softbank Aim To Transform Healthcare
Oshi Health names ACG, AGA as additional investors in funding round
Oracle shares jump 7% on involvement in AI infrastructure initiative that Trump will announce

Share This Article